Jun 10, 2021 (Heraldkeepers) —

The global Pharmacogenomics Market is expected to reach USD 11.97 Billion by 2027, according to a new report by Emergen Research. The global pharmacogenomics (PGx) market is growing at a substantial pace owing to the growing demand for personalized therapy, increasing prevalence of target chronic diseases, technological advancements, favorable government initiatives, availability of financial support for research and development.

Get a free exclusive sample of Pharmacogenomics market report: https://www.emergenresearch.com/request-sample/88

Pharmacogenomics has high demand; therefore, research centers invest a handful of the amount in their R&D, which fuels up the market growth by a large margin. Pharmacogenomics also may help to quickly identify the best drugs to treat people with certain mental health disorders. Cancer is another active area of pharmacogenomic research. Whether fighting a unique and fast-spreading disease like the novel coronavirus or treating a well-known common condition, genomics is increasingly being used to inform more personalized and cost-effective strategies for drug development and use. Such advantages are expected to foster the market significantly during the forecast period.

Clinical trials are now underway to learn whether genetic tests that predict SSRI response can improve patients’ outcomes. Pharmacogenomics, a cornerstone of precision medicine, is proving successful for many conditions. Increasing R&D will impact the market substantially in recent years.

The latest market intelligence report, titled ‘Global Pharmacogenomics Market’, is intended to provide the target audience with the necessary information about the global Pharmacogenomics industry.

Key Highlights of the Pharmacogenomics Market Report:

  • The pharmacogenomics by application includes Oncology as one of the prospects which are expected to fuel the market growth. Pharmacogenomics is expected to help guide healthcare professionals to personalize treatment for cancer patients, which will contribute significantly to the market.
  • Research organizations held a significant share in 2019, owing to its contribution to the research field. It is a relatively new field that combines pharmacology and genomics to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.
  • The major driving factors for the growth of this market in the North American region is the rising demand for personalized medicines, high medical reimbursement facilities, and technological advancement.
  • Key participants include Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporation of America Holdings, among others.

The report contains unbiased industry expert opinions on the current market scenario, past market performance, production & consumption rates, demand & supply ratio, and revenue generation forecasts over the estimated period. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the Pharmacogenomics market players.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.emergenresearch.com/purchase-enquiry/88

The research study presents an industry-wide summary of the Pharmacogenomics market, including drivers, constraints, technological advancements, product developments, limitations, growth strategies, growth prospects, etc. among others. The Pharmacogenomics7 report analyzes the market based on different categories, such as product types, end-user applications, and leading geographical regions.

Segmental Analysis:

The Pharmacogenomics market report provides an in-depth analysis of the key competitors operating in the industry. The report offers insights into their product portfolio, business overview, financial standing, market position, revenue generation, market share and market size, and production and manufacturing capacity along with pricing analysis.

Product and Services Outlook (Revenue, USD Billion; 2017-2027)

  • Products
    1. Kits
    2. Assays and Reagents
    3. Instruments
    4. Software
  • Services
    1. Genotyping
    2. SNP Identification
    3. Pharmacogenetic Testing
    4. Other Services
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • Polymerase Chain Reaction (PCR)
      1. Real-Time PCR
      2. qPCR
      3. Digital PCR
    • DNA Sequencing/Next Generation Sequencing (NGS)
    • Nucleic Acid Amplification Tests (NAATs)
    • Mass Spectrometry
    • Gel Electrophoresis
    • Hybridization
      1. Fluorescence In Situ Hybridization (FISH)
      2. Chromogenic In Situ Hybridization (CISH)
      3. Others
    • Microarray
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Oncology
    • Infectious Diseases
    • Neurology/Psychiatry
    • Cardiovascular
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2017-2027)
    • Research Organization
    • Pharmaceutical Companies
    • Diagnostic Centers
    • Others

To get a discount on the Global Pharmacogenomics Market report, visit: https://www.emergenresearch.com/request-discount/88

Regional Analysis:

The Pharmacogenomics industry report mainly focuses on the key market regions where the market is spread, including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report further focuses on the key segments of the market, such as product types, application spectrum, technology, end-user industries, among others.

Major Geographies Analyzed in the Report:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Questions Answered in the Report:

  • What is the growth rate of the Pharmacogenomics market? What is the anticipated market valuation of the Pharmacogenomics industry by 2027?
  • What are the key growth driving and restraining factors of the Pharmacogenomics market?
  • Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
  • What are the key opportunities and growth prospects of the Pharmacogenomics industry over the forecast period?
  • Which region is expected to show significant growth in the coming years?

Read more: https://www.emergenresearch.com/industry-report/pharmacogenomics-market

Related report

Pulse Oximeter Market Analysis By Product (Hand-held, Fingertip, Tabletop, Wrist-worn, Others), By Sensor Type (Reusable, Disposable) By End Use (Hospitals, Healthcare & Diagnostic Centers, Home Care), By Region, Forecasts To 2027

Interventional Cardiology Market By Product (Catheters, Angioplasty Balloons, Plaque Modification Devices, Angioplasty Stents), By End Users (Cardiac Catheterization labs, Hospitals, Ambulatory surgical centers), Forecasts to 2027

Digital Scent Technologies Market By Product Type (Mobile Phone & Computer, Virtual Reality, Medical Diagnostic), By Application (Marketing, Entertainment, Education, Healthcare, Communication), By Component (Hardware, E-Nose, Scent Synthesizer, Software) and Regions Forecasts to 2027

Single Cell Sequencing Market By Product, By Workforce, By Technology, By Diseases Type (Oncology, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology), By Application (Circulating Cells, Cell Differentiation/Reprogramming, Subpopulation Characterization, Genomic Variation), By End-Use, Forecasts to 2027

Automotive LiDAR Market By Image Type (2D Image Type, 3D Image Type) By Technology (Solid-State LiDAR, Mechanical/Scanning LiDAR), By Vehicle Type (ICE, HEV, PHEV), By Application, By Location, and By Region, Forecasts to 2027

Nanofilms Market: https://www.emergenresearch.com/industry-report/nanofilms-market

Synthetic Blood Substitutes Market: https://www.emergenresearch.com/industry-report/synthetic-blood-substitutes-market

Polylactic Acid Market: https://www.emergenresearch.com/industry-report/polylactic-acid-market

3D Printing Market: https://www.emergenresearch.com/industry-report/3d-printing-market

CRISPR Technology Market: https://www.emergenresearch.com/industry-report/crispr-technology-market

Molecular Diagnostics Point of Care Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market

Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market3D Printing Materials Market

Air Purifier Market

Automotive Cybersecurity Market

Automotive Refinish Coatings Market

Cancer Tumor Profiling Market

Sustainable Packaging Market

Deep Brain Stimulation Systems Market

Radiotherapy Market

Heart rhythm devices Market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs

comtex tracking

COMTEX_388098658/2582/2021-06-10T11:18:55

********************************************************************** As of Sunday, 06-06-2021 23:59, the latest Comtex SmarTrend® Alert, an automated pattern recognition system, indicated a DOWNTREND on 06-04-2012 for ABT @ $60.27. As of Sunday, 0

Please read the End User Agreement.

By accessing this page, you agree to the terms and conditions of the End User Agreement.

News provided by COMTEX.


Extreme Futures: Movers & Shakers

Hottest

Actives

Gainers

Today’s Hottest Futures
MarketLastVol% Chg
Loading…

Extreme Futures: Movers & Shakers

Hottest

Actives

Gainers

Futures Activity Leaders
MarketLastVol% Chg
Loading…

Extreme Futures: Movers & Shakers

Hottest

Actives

Gainers

Top Price Gainers
MarketLastVol% Chg
Loading…


world.einnews.com

Read Source